Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New oral glucose solution vs oral glucose powder for OGTT
CTR20255125Phase 3Active
- Sponsor
- Guoren Health Pharmaceutical
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glucose (2 arms), sponsored by Guoren Health Pharmaceutical. Primary endpoint: Consistency of OGTT results between new oral glucose solution and oral glucose powder. Started Mar 2026; status: active.
02
Drugs
glucose
Beyond the preview
Go deeper on CTR20255125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255125.